Catalent is investing $50 million to install an additional high-speed vial filling line at its Bloomington, IN facility. The new line is expected to be operational by April 2021 and will add capacity to support the growing pipeline of clinical programs and commercial launches at the site. It will provide sufficient capacity to produce up to 80 million vials annually under barrier isolator technology and a peristaltic pump filling mechanism, consistent with cGMP regulations. The Bloomington s...